What to Expect From Medtronic's Next Quarterly Earnings Report

Core Insights - Medtronic plc (MDT) is valued at a market cap of $126.4 billion and is set to announce its fiscal Q3 earnings for 2026 on February 17 [1] Financial Performance - Analysts expect MDT to report a profit of $1.33 per share for fiscal Q3 2026, a decrease of 4.3% from $1.39 per share in the same quarter last year [2] - For fiscal 2026, analysts project a profit of $5.64 per share, reflecting a 2.7% increase from $5.49 per share in fiscal 2025, with further growth expected to $6.13 per share in fiscal 2027 [3] Stock Performance - Over the past 52 weeks, MDT's shares have increased by 13.5%, slightly lagging behind the S&P 500 Index's return of 13.7%, but outperforming the State Street Health Care Select Sector SPDR ETF's increase of 11.1% [4] - Following the release of better-than-expected Q2 results, MDT's shares surged by 4.7%, with overall revenue rising 6.6% year-over-year to $9 billion, exceeding consensus estimates by 1.1% [5] Analyst Ratings - Wall Street analysts maintain a "Moderate Buy" rating for MDT, with 11 out of 27 analysts recommending "Strong Buy," one suggesting "Moderate Buy," and 15 indicating "Hold" [6] - The average price target for MDT is $110.71, suggesting a potential upside of 10.4% from current levels [6]